1972
DOI: 10.1001/archderm.1972.01620150025009
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Efficacy Studies of Haloprogin, a New Topical Antimicrobial Agent

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

1973
1973
2009
2009

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(7 citation statements)
references
References 2 publications
0
7
0
Order By: Relevance
“…This is a halogenated phenolic ether that is fungicidal to Malassezia. 139 It is an effective treatment for pityriasis versicolor 146 …”
Section: Treatmentmentioning
confidence: 99%
“…This is a halogenated phenolic ether that is fungicidal to Malassezia. 139 It is an effective treatment for pityriasis versicolor 146 …”
Section: Treatmentmentioning
confidence: 99%
“…Other side effects experienced by patients using haloprogin included irritation and burning on application. Previous trials using i";, haloprogin cream reported no adverse reactions (Carter, 1972;Katz & Cahn, 1972) but Hermann (1972) recorded irritation in 8 patients and a burning sensation in one patient out of a total of 472 with either dermatophyte or Candida infections treated with 1% haloprogin cream for 14 days. Allergic contact dermatitis from haloprogin cream and haloprogin solution has been reported (Berlin & Miller, 1976;Moss, 1974).…”
Section: Discussionmentioning
confidence: 90%
“…Harrison et al (1970) confirmed its antigungal activity and also showed it to be effective against yeasts and some gram-positive bacteria. Haloprogin has been found to be clinically effective for dermatophyte infections (Katz & Cahn, 1972;Hermann, 1972;Carter, 1972) and for cutaneous candidiasis (Carter & Olansky, 1974;Montes & Hermann, 1973).…”
Section: Introductionmentioning
confidence: 99%
“…Another testing complication is that the growth of a dermatophyte on a nutrient culture medium is not comparable to its growth on stratum corneum in vivo or in vitro [52][53] . Furthermore, in human experimental infections, investigators have found difficulty in detecting a therapeutic effect because of the natural remission of the infections [54] . Clinical trials are also difficult to control because of the lack of uniformity of naturally occurring lesions.…”
Section: In Vivo Versus In Vitromentioning
confidence: 99%